Stock & Company Details
Annexon Inc $ANNX
Price:
N/A
N/A
190M
$766M
52 Week High:
N/A
10 Day Average Volume:
N/A
-3.33
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
ANNX technical indicators
Latest Annexon Inc (ANNX) indicator readings as of 2026-10-29.
ANNX's 14-day RSI is 51.2, in neutral territory. At $4.01 it is trading 23.4% below its 200-day moving average of $5.23, and below its 50-day average of $4.23. Price sits in the middle of its Bollinger Bands ($3.50 to $4.27). ADX reads 17.1, indicating a range-bound market rather than a trend.
Overview
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Annexon's product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; and ANX009, for systemic autoimmune diseases.
Finance Bot
Ask your questions
Start by typing a question below.
